BELITE BIO INC - AMERICAN DEPOSITARY SHARES

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

12 6 2024 02:55:28 提供 Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

14 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

13 5 2024 21:50:29 提供 Nasdaq GlobeNewswire

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

08 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant

06 5 2024 08:15:00 提供 Nasdaq GlobeNewswire

Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting

06 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

01 5 2024 16:15:00 提供 Nasdaq GlobeNewswire

Belite Bio Announces $25 Million Registered Direct Offering

25 4 2024 19:15:29 提供 Nasdaq GlobeNewswire

Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan

22 3 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

11 3 2024 22:28:39 提供 Nasdaq GlobeNewswire

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

11 3 2024 21:27:47 提供 Nasdaq GlobeNewswire

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results

06 3 2024 08:00:01 提供 Nasdaq GlobeNewswire

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

04 3 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

07 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

30 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio to Participate in the BTIG Ophthalmology Day

20 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results

13 11 2023 20:15:47 提供 Nasdaq GlobeNewswire

Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results

07 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting

06 11 2023 08:00:00 提供 Nasdaq GlobeNewswire